| Literature DB >> 24441767 |
Olivier Boucher1, Gina Muckle, Joseph L Jacobson, R Colin Carter, Melissa Kaplan-Estrin, Pierre Ayotte, Éric Dewailly, Sandra W Jacobson.
Abstract
BACKGROUND: Polychlorinated biphenyls (PCBs), methylmercury (MeHg), and lead (Pb) are environmental contaminants known for their adverse effects on cognitive development.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24441767 PMCID: PMC3948023 DOI: 10.1289/ehp.1206323
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Descriptive data for the study sample (n = 94).
| Variable | Mean ± SD | Median | Range | Percent | |
|---|---|---|---|---|---|
| Infant characteristics | |||||
| Sex (% males) | 94 | 63.8 | |||
| Age at 6.5-month testing (weeks) | 91 | 30.4 ± 3.5 | 29.9 | 25.6–40.9 | |
| Age at 11-month testing (weeks) | 90 | 50.5 ± 6.9 | 47.8 | 43.2–81.1 | |
| Birth weight (g) | 94 | 3566.7 ± 461.8 | 3,550 | 2,440–4,560 | |
| Gestation duration (weeks) | 94 | 39.2 ± 1.5 | 39.0 | 36.0–42.0 | |
| Adoption status (% adopted) | 94 | 10.6 | |||
| Maternal and family characteristics | |||||
| Age at prenatal interview (years) | 94 | 24.6 ± 5.8 | 24.3 | 15.3–39.0 | |
| Parity (no. of live births) | 94 | 2.1 ± 1.8 | 2 | 0–9 | |
| Marital status (% married or living with someone) | 94 | 69.1 | |||
| Breastfeeding (weeks) (% yes) | 93 | 26.3 ± 17.1 | 24.3 | 0.1–57.3 | 87.1 |
| Social environment composite measure | 94 | 0.0 ± 0.5 | 0.1 | –1.3–1.3 | |
| Maternal education (years) | 94 | 8.9 ± 1.7 | 9.0 | 5.5–14.3 | |
| Maternal nonverbal reasoning abilities | 94 | 34.6 ± 8.1 | 36 | 13–48 | |
| Socioeconomic status | 94 | 25.5 ± 9.5 | 24.8 | 8–44 | |
| HOME | 85 | 31.6 ± 5.2 | 32 | 19–41 | |
| Language at interview (% Inuktitut) | 94 | 18.1 | |||
| Maternal consumption during pregnancy | |||||
| Cigarettes (no./day) (% yes) | 94 | 10.8 ± 5.7 | 10.3 | 1–25 | 93.6 |
| Binge drinking (≥ 5 standard drinks of alcohol per occasion) (% yes) | 94 | 39.4 | |||
| Marijuana (% yes) | 94 | 40.4 | |||
| Contaminants and nutrients | |||||
| Cord plasma PCB-153 (μg/kg lipids) | 92 | 114.8 ± 96.0 | 78.1 | 12.0–550.9 | |
| Cord blood Hg (μg/L) | 91 | 22.5 ± 16.6 | 17.0 | 2.4–97.3 | |
| Cord blood Pb (μg/dL) | 93 | 4.8 ± 3.5 | 3.5 | 0.5–17.8 | |
| Cord plasma DHA (% phospholipids) | 90 | 3.7 ± 1.2 | 3.7 | 1.3–7.5 | |
| Cord blood Se (μg/L) | 91 | 296.4 ± 122.8 | 268.5 | 67.9–915.9 | |
| FTII | |||||
| Novelty preference, 6.5 months (%) | 89 | 57.9 ± 6.2 | 58.0 | 39.0–74.0 | |
| Novelty preference, 11 months (%) | 89 | 59.5 ± 6.3 | 59.4 | 38.0–74.0 | |
| Fixation duration, 6.5 months (sec) | 89 | 1.9 ± 0.4 | 1.8 | 1.0–3.2 | |
| Fixation duration, 11 months (sec) | 89 | 1.7 ± 0.3 | 1.6 | 1.2–2.6 | |
| A-not-B | |||||
| Length of delay–2 correct | 77 | 1.8 ± 2.2 | 0 | 0–9 | |
| Length of delay–3 correct | 77 | 1.4 ± 2.0 | 0 | 0–7 | |
| Perseverative errors (%) | 73 | 19.6 ± 15.6 | 17.7 | 0–69 | |
| BSID-II | |||||
| MDI | 87 | 94.2 ± 7.6 | 95 | 76–115 | |
| PDI | 87 | 89.5 ± 11.5 | 89 | 58–120 | |
| WISC-IV at 11 years | |||||
| Full-Scale IQ | 64 | 88.8 ± 8.7 | 88 | 72–108 | |
| Disruptive Behavior Scale at 11 years | |||||
| ADHD | 60 | 30.0 | |||
Pearson correlations relating confounding variables to infant outcomes (n = 94).
| Variable | FTII, 6.5 months | FTII, 11 months | A-not-B | BSID-II | |||||
|---|---|---|---|---|---|---|---|---|---|
| Novelty preference | Fixation duration | Novelty preference | Fixation duration | Length of delay–2 correct | Length of delay–3 correct | Perseverative errors (%) | MDI | PDI | |
| Infant characteristics | |||||||||
| Sex (females = 1; males = 2) | 0.05 | 0.01 | –0.02 | –0.02 | 0.05 | 0.03 | 0.10 | 0.04 | –0.05 |
| Age at testing | –0.10 | –0.14 | –0.31** | –0.26* | 0.28* | 0.27* | –0.32** | 0.14 | –0.01 |
| Birth weight | 0.12 | –0.09 | –0.05 | –0.09 | –0.07 | –0.01 | –0.05 | 0.19# | 0.18# |
| Maternal and family characteristics | |||||||||
| Age | –0.13 | 0.12 | –0.12 | 0.12 | 0.01 | 0.04 | 0.19 | –0.03 | –0.04 |
| Parity | –0.04 | –0.05 | –0.10 | 0.08 | 0.05 | 0.05 | 0.03 | –0.05 | 0.09 |
| Social environment | –0.04 | –0.38** | 0.00 | –0.23* | 0.14 | 0.10 | –0.15 | 0.29** | 0.15 |
| Maternal consumption during pregnancy | |||||||||
| Cigarettes | –0.10 | 0.01 | –0.07 | 0.16 | 0.14 | 0.10 | –0.14 | 0.04 | 0.13 |
| Binge drinking (0 = no; 1 = yes) | 0.05 | –0.01 | 0.11 | 0.09 | 0.11 | 0.13 | 0.02 | 0.09 | –0.09 |
| Marijuana (0 = no; 1 = yes) | 0.05 | 0.10 | –0.09 | 0.05 | 0.04 | 0.00 | –0.01 | –0.03 | –0.25* |
| Nutrients | |||||||||
| Cord plasma DHA (% phospholipids) | 0.20# | –0.09 | –0.03 | –0.04 | –0.10 | –0.10 | –0.13 | 0.19# | 0.12 |
| Cord blood Se (μg/L) | 0.09 | 0.13 | –0.02 | 0.09 | –0.06 | –0.05 | –0.21# | 0.10 | –0.10 |
|
# | |||||||||
Associations between contaminant concentrations in cord blood (ln-transformed) and test performance [β (95% CI)].
| Outcomes | PCB-153 | Mercury | Lead | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | |
| FTII | |||||||||
| Novelty preference | –0.14 (–0.30, 0.02)# | –0.14 (–0.30, 0.02)# | –0.17 (–0.34, 0.00)* | 0.03 (–0.14, 0.20) | 0.03 (–0.15, 0.20) | 0.00 (–0.19, 0.19) | –0.12 (–0.28, 0.04) | –0.14 (–0.31, 0.03)# | –0.13 (–0.31, 0.05) |
| Fixation duration | 0.07 (–0.07, 0.21) | 0.09 (–0.05, 0.22) | 0.09 (–0.05, 0.24) | 0.14 (–0.01, 0.29)# | 0.11 (–0.03, 0.26) | 0.13 (–0.03, 0.29)# | 0.21 (0.07, 0.35)** | 0.15 (0.01, 0.29)* | 0.21 (0.07, 0.35)** |
| A-not-B | |||||||||
| Length of delay–2 correct | –0.12 (–0.34, 0.11) | –0.20 (–0.41, 0.02)# | –0.15 (–0.36, 0.07) | –0.22 (–0.43, 0.01)# | –0.30 (–0.49, –0.07)** | –0.25 (–0.46, 0.00)* | –0.12 (–0.35, 0.11) | –0.11 (–0.35, 0.13) | –0.08 (–0.30, 0.15) |
| Length of delay–3 correct | –0.14 (–0.36, 0.10) | –0.23 (–0.44, –0.01)* | –0.18 (–0.40, 0.05) | –0.20 (–0.42, 0.03)# | –0.28 (–0.49, –0.05)* | –0.22 (–0.45, 0.03)# | –0.08 (–0.31, 0.15) | –0.08 (–0.32, 0.16) | –0.05 (–0.28, 0.19) |
| Perseverative errors (%) | 0.10 (–0.14, 0.35) | 0.21 (–0.03, 0.47)# | 0.20 (–0.04, 0.47)# | –0.27 (–0.52,–0.04)* | –0.15 (–0.45, 0.13) | –0.21 (–0.53, 0.09) | 0.07 (–0.17, 0.31) | 0.04 (–0.20, 0.29) | –0.00 (–0.27, 0.27) |
| BSID-II | |||||||||
| MDI | 0.08 (–0.15, 0.31) | 0.07 (–0.14, 0.29) | 0.03 (–0.20, 0.26) | 0.10 (–0.13, 0.33) | 0.12 (–0.10, 0.35) | 0.08 (–0.15, 0.33) | –0.05 (–0.28, 0.17) | 0.03 (–0.19, 0.25) | –0.02 (–0.26, 0.23) |
| PDI | 0.00 (–0.22, 0.23) | –0.02 (–0.24, 0.20) | –0.05 (–0.28, 0.18) | 0.04 (–0.19, 0.28) | 0.04 (–0.19, 0.27) | 0.01 (–0.24, 0.25) | –0.09 (–0.32, 0.13) | –0.03 (–0.26, 0.19) | –0.05 (–0.30, 0.20) |
| Values are standardized regression coefficients (95% CIs) for multiple regression analyses (with repeated measures for FTII measures). Model 1: univariate model; model 2 = multivariable model adjusting for potential confounders (FTII outcomes and A-not-B Length of delay: infant age at testing, social environment composite; A-not-B Perseverative errors: infant age at testing, social environment composite, cord Se; MDI: social environment composite, birth weight; PDI: social environment composite, maternal marijuana during pregnancy); model 3, multivariable model adjusting for potential confounders and DHA. # | |||||||||
Figure 1Dose–response analyses relating prenatal PCB exposure to FTII novelty preference at 6.5 (A) and 11 (B) months, adjusted for child age, social environment, and DHA; (C) prenatal Hg to A-not-B Length of delay–2 correct adjusted for child age and social environment; and Pb to FTII fixation duration at 6.5 (D) and 11 (E) months, adjusted for child age and social environment. Adjusted means were computed by summing the residuals from the each of the regression analyses (including each confounder). Error bars represent ± 1 SE.